February 25, 2021

De-risking the Manufacturing of Cell Therapies through Virus-Inactivated Products, Upcoming Webinar Hosted by Xtalks

January 20, 2021

Akron Biotech Signs Exclusive Global Agreement with Octapharma to Produce Virally Inactivated Human AB Serum Derived from Octaplas® for the Cell Therapy Market

October 26, 2020

Akron Biotech Acquires Cytiva FlexFactory for the Manufacture of Plasmid DNA

October 18, 2020

Akron Biotech Signs Agreement with Synairgen plc to Supply Interferon-beta for COVID-19 Treatment

July 13, 2020

Akron Submits eCTD Drug Master Files with FDA for its Suite of cGMP Immunotherapy Cytokines